American Journal of Clinical Dermatology

Article	Citations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	290
Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE	131
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	108
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	97
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	81
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	80
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review	77
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma	75
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	74
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	72
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study	72
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials	70
The Burden of Pediatric Psoriasis: A Systematic Review	68
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	66
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	65
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	63
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	61
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	59
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	56
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks	55
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	54
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	52
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	52
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	51
Skin Cancer in Solid Organ Transplant Recipients: A Review	50

Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	50
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry	49
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients	49
Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium	48
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	47
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	46
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	45
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	44
Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!	44
A Practice Approach to Acne Fulminans in Adolescents	44
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	44
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	41
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances	39
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review	39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	38
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	37
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	35
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	35
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	33
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	32
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	31
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	30
Exposome Risk Factors for Vitiligo: A Systematic Evidence Review	30
Oral Lichen Planus: An Update on Diagnosis and Management	30
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	29
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	29
Individualized Neoantigen-Directed Melanoma Therapy	28
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States	28
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review	28
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	28
Advancing Precision Medicine in Inflammatory Skin Disease	27
Frontal Fibrosing Alopecia: An Update	27
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	27
The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?	27
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	27
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	26
Targeting Inflammation in Acne: Current Treatments and Future Prospects	24
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	24
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	24
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	24
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management	23
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	23
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	23
Acknowledgement to Referees	23
Acknowledgement to Referees	23
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	22
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	22
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review	22
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results	22
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	22

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment	22
Management of Acne in Pregnancy	21
Approach to the Atypical Wound	20
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	20
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	19
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	19
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	19
Safety of Hydroxychloroquine: What a Dermatologist Should Know	18
Is There a Place for Biologics in Acne?	17
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	17
Real-World Treatment with Lebrikizumab or Tralokinumab for Atopic Dermatitis: A 60-Week Retrospective Comparative Study	17
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	17
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	17
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	17
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	16
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	16
An Update on New and Existing Treatments for the Management of Melasma	16
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations	16
High-Frequency Ultrasound in Hidradenitis Suppurativa: From Lesion Detection to Iconographic Lesion-Level Management	16
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	16
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	15
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	15
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	15
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	15
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	14
Treatment of Hyperhidrosis: An Update	14
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	14
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	14
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	14
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	14
Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study	14
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	13
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	13
Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients	13
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	13
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	13
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	12
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	12
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	12
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	12
Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study	12
Genomics of Primary and Metastatic Cutaneous Melanoma: A Systematic Review and Meta-Analysis	12
Atopic Dermatitis Across Shades of Skin	12
Mastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide	12
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	12
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks	11
Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies	11
Lichen Planus: What is New in Diagnosis and Treatment?	11
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies	11
Alopecia in Children with Cancer: A Review from Pathophysiology to Management	11
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	11
Dapsone Use in Dermatology	11
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	11
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases	10
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis	10
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	10
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	10
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast	10
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	10
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	10
Correction to: Adherence to Hidradenitis Suppurativa Treatment	10
What’s New in Therapy for Male Androgenetic Alopecia?	9
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	9
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	9
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review	9
Alopecia Areata: Current Treatments and New Directions	9
Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic Porphyrias	9
Eyebrow and Eyelash Alopecia: A Clinical Review	9
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	8
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis	8
Adherence to Hidradenitis Suppurativa Treatment	8
Deucravacitinib for the Treatment of Psoriatic Disease	8
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	8
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	8
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase	7
Understanding Enthesitis in Psoriatic Disease: Insights and Implications	7
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	7
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	7
Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology	7
Acute and Chronic Cutaneous Graft-versus-Host Disease: Diagnosis, Treatment, and Emerging Directions	7

Psoriasis: Considerations for the Management of Women of Childbearing Potential	7
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	7
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS)	7
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	7
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	7
Nicotinamide for Skin Cancer Chemoprevention: The Jury Was Out and Still is	6
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	6
Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis	6
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	6
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies	6
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study	6
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	6
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	6
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	6
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	6
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	6
Perioperative Systemic Therapy for High-Risk Cutaneous Squamous Cell Carcinoma	6
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	6
Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	6